Stephen Grubbs
Overview
Explore the profile of Stephen Grubbs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
78
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ng D, Belinske S, Hollinger D, Nagarajan S, Little H, Grubbs S, et al.
Dela J Public Health
. 2024 Aug;
10(3):38-44.
PMID: 39211400
A previously initiated statewide effort in Delaware improved outcomes in colorectal cancer (CRC) racial disparities. To examine whether improvements in racial disparities for CRC have been sustained a decade later...
2.
Bourbeau B, Hagerty K, Dickson N, Polite B, Chasky M, Grubbs S
JCO Oncol Pract
. 2022 Oct;
18(11):737-741.
PMID: 36252157
No abstract available.
3.
Pennell N, Dillmon M, Levit L, Moushey E, Alva A, Blau S, et al.
J Clin Oncol
. 2020 Dec;
39(2):155-169.
PMID: 33290128
This report presents the American Society of Clinical Oncology's (ASCO's) evaluation of the adaptations in care delivery, research operations, and regulatory oversight made in response to the coronavirus pandemic and...
4.
Blayney D, Albdelhafeez N, Jazieh A, Pinto C, Udrea A, Roach A, et al.
JCO Glob Oncol
. 2020 May;
6:697-703.
PMID: 32374622
No abstract available.
5.
Bruinooge S, Sherwood S, Grubbs S, Schilsky R
J Oncol Pract
. 2019 Aug;
15(11):575-583.
PMID: 31386607
Targeted cancer therapies are drugs and biologics designed to affect cancer cell growth by blocking or interfering with specific molecular pathways in the cancer cell. Use of targeted agents usually...
6.
Laslett N, Park S, Masters G, Biggs D, Schneider C, Misleh J, et al.
Cancer Med
. 2018 Jun;
7(7):2969-2973.
PMID: 29905018
Lung cancer remains the leading cause of cancer death throughout the world. Despite new chemotherapeutic, immunomodulating and molecularly targeted agents, patients with locally advanced or metastatic disease still have a...
7.
Jagsi R, Spence R, Rathmell W, Bradbury A, Peppercorn J, Grubbs S, et al.
Oncologist
. 2014 Jan;
19(2):186-92.
PMID: 24449096
Shortages of injectable drugs affect many cancer patients and providers in the U.S. today. Scholars and policymakers have recently begun to devote increased attention to these issues, but only a...
8.
Paskett E, Herndon 2nd J, Donohue K, Naughton M, Grubbs S, Pavy M, et al.
Cancer
. 2009 Jan;
115(5):1109-20.
PMID: 19170232
Background: The Survivor's Health and Reaction (SHARE) study examined health-related quality of life (HRQL) in breast cancer patients who had participated in Cancer and Leukemia Group B Trial 8541 from...
9.
Petrelli N, Grubbs S, Price K
J Clin Oncol
. 2008 May;
26(15):2440-1.
PMID: 18487564
No abstract available.